Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial
Disselhorst, Maria J, Quispel-Janssen, Josine, Lalezari, Ferry, Monkhorst, Kim, de Vries, Jeltje F, van der Noort, Vincent, Harms, Emmy, Burgers, Sjaak, Baas, Paul
Published in The lancet respiratory medicine (01.03.2019)
Published in The lancet respiratory medicine (01.03.2019)
Get more information
Journal Article
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B‐cell precursor acute lymphoblastic leukaemia
Velden, Vincent H. J., Launaij, Daphne, Vries, Jeltje F., Haas, Valerie, Sonneveld, Edwin, Voerman, Jane S. A., Bie, Maaike, Revesz, Tamas, Avigad, Smadar, Yeoh, Allen E. J., Swagemakers, Sigrid M. A., Eckert, Cornelia, Pieters, Rob, Dongen, Jacques J. M.
Published in British journal of haematology (01.03.2016)
Published in British journal of haematology (01.03.2016)
Get full text
Journal Article
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Quispel-Janssen, Josine, van der Noort, Vincent, de Vries, Jeltje F., Zimmerman, Marion, Lalezari, Ferry, Thunnissen, Erik, Monkhorst, Kim, Schouten, Robert, Schunselaar, Laurel, Disselhorst, Maria, Klomp, Houke, Hartemink, Koen, Burgers, Sjaak, Buikhuisen, Wieneke, Baas, Paul
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial
Theelen, Willemijn S M E, Peulen, Heike M U, Lalezari, Ferry, van der Noort, Vincent, de Vries, Jeltje F, Aerts, Joachim G J V, Dumoulin, Daphne W, Bahce, Idris, Niemeijer, Anna-Larissa N, de Langen, Adrianus J, Monkhorst, Kim, Baas, Paul
Published in JAMA oncology (01.09.2019)
Published in JAMA oncology (01.09.2019)
Get more information
Journal Article
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
Douma, Li-Anne H, Lalezari, Ferry, van der Noort, Vincent, de Vries, Jeltje F, Monkhorst, Kim, Smesseim, Illaa, Baas, Paul, Schilder, Bodien, Vermeulen, Marrit, Burgers, Jacobus A, de Gooijer, Cornedine J
Published in The lancet oncology (01.11.2023)
Published in The lancet oncology (01.11.2023)
Get full text
Journal Article
Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing
de Vries, Jeltje F, von dem Borne, Peter A, van Luxemburg-Heijs, Simone A.P, Heemskerk, Mirjam H.M, Willemze, Roel, Falkenburg, J.H. Frederik, Barge, Renee M.Y
Published in Haematologica (Roma) (01.12.2007)
Published in Haematologica (Roma) (01.12.2007)
Get full text
Journal Article
The potential use of basigin (CD147) as a prognostic marker in B‐cell precursor acute lymphoblastic leukaemia
De Vries, Jeltje F., Te Marvelde, Jeroen G., Wind, Henk K., Van Dongen, Jacques J. M., Van Der Velden, Vincent H. J.
Published in British journal of haematology (01.09.2010)
Published in British journal of haematology (01.09.2010)
Get full text
Journal Article